Table 4 GLUL polymorphism rs10911021 and characteristics of subjects among the studied groups
From: GLUL rs10911021 polymorphism and risk of coronary artery disease among Egyptian individuals
CAD with T2DM (N = 240) | CAD (N = 180) | |||||
|---|---|---|---|---|---|---|
T (%) | C (%) | p value | T (%) | C (%) | p value | |
Height (cm) | 164.9 ± 9.9 | 167.9 ± 10 | 0.047* | 168.24 ± 7.5 | 170.4 ± 7.4 | 0.064 |
Weight (kg) | 91.49 ± 10.4 | 90.04 ± 12.6 | 0.42 | 99.89 ± 14 | 93.26 ± 9 | 0.002** |
Waist (cm) | 113.38 ± 9.6 | 107.66 ± 11 | < 0.001** | 107.82 ± 12 | 100.5 ± 11.3 | < 0.001* |
BMI (kg/m2) | 33.7579 ± 4 | 32.0069 ± 4 | 0.004** | 35.4 ± 5.4 | 32.3 ± 4.2 | < 0.001* |
SBP (mmHg) | 151.08 ± 18 | 140.44 ± 15 | < 0.001** | 155 ± 18 | 145.97 ± 15 | 0.001** |
DBP (mmHg) | 94.85 ± 15 | 86.41 ± 10 | < 0.001** | 97.45 ± 15 | 90.48 ± 11 | 0.002** |
FBS (mg/dL) | 202.02 ± 49 | 210.70 ± 62 | 0.323 | 94.04 ± 21 | 92.8 ± 21.5 | 0.711 |
2HPP (mg/dL) | 236.308 ± 70 | 249.437 ± 88 | 0.258 | 101.63 ± 20 | 100 ± 19.3 | 0.646 |
HbA1c % | 8.3077 ± 1.5 | 8.3511 ± 1.5 | 0.85 | 5.761 ± 0.8 | 5.6 ± 0.74 | 0.055 |
CHOL (mg/dL) | 220.462 ± 49 | 201.852 ± 52 | 0.017* | 227.4 ± 65 | 202.78 ± 58 | 0.01* |
TG (mg/dL) | 184.015 ± 35 | 196.230 ± 87 | 0.161 | 183.61 ± 61 | 166.58 ± 64 | 0.091 |
HDL (mg/dL) | 31.677 ± 7.5 | 35.859 ± 9.0 | 0.002** | 33.14 ± 9.5 | 33.19 ± 9.2 | 0.974 |
LDL (mg/dL) | 152 ± 51.5 | 124.519 ± 47 | < 0.001** | 157.07 ± 61 | 135.17 ± 56 | 0.017* |
CRP (mg/L) | 124.7 ± 55 | 113.7 ± 61 | 0.221 | 129.82 ± 42 | 116.8 ± 47 | 0.076 |
INS (mIU/L) | 10.8 ± 28 | 11.58 ± 23.0 | 0.828 | 12.18 ± 16 | 14.6 ± 16.7 | 0.34 |
PON1 (mIU/mL) | 22.75 ± 7.2 | 27.3 ± 14 | 0.021* | 25.87 ± 6 | 25.8 ± 8 | 0.993 |